Safety assessment of probiotics for human use
Top Cited Papers
- 1 May 2010
- journal article
- review article
- Published by Taylor & Francis Ltd in Gut Microbes
- Vol. 1 (3), 164-185
- https://doi.org/10.4161/gmic.1.3.12127
Abstract
The safety of probiotics is tied to their intended use, which includes consideration of potential vulnerability of the consumer or patient, dose and duration of consumption, and both the manner and frequency of administration. Unique to probiotics is that they are alive when administered, and unlike other food or drug ingredients, possess the potential for infectivity or in situ toxin production. Since numerous types of microbes are used as probiotics, safety is also intricately tied to the nature of the specific microbe being used. The presence of transferable antibiotic resistance genes, which comprises a theoretical risk of transfer to a less innocuous member of the gut microbial community, must also be considered. Genetic stability of the probiotic over time, deleterious metabolic activities, and the potential for pathogenicity or toxicogenicity must be assessed depending on the characteristics of the genus and species of the microbe being used. Immunological effects must be considered, especially in certain vulnerable populations, including infants with undeveloped immune function. A few reports about negative probiotic effects have surfaced, the significance of which would be better understood with more complete understanding of the mechanisms of probiotic interaction with the host and colonizing microbes. Use of readily available and low cost genomic sequencing technologies to assure the absence of genes of concern is advisable for candidate probiotic strains. The field of probiotic safety is characterized by the scarcity of studies specifically designed to assess safety contrasted with the long history of safe use of many of these microbes in foods.Keywords
This publication has 183 references indexed in Scilit:
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- Bacterial Tag–Encoded FLX Amplicon Pyrosequencing (bTEFAP) for Microbiome Studies: Bacterial Diversity in the Ileum of Newly WeanedSalmonella-Infected PigsFoodborne Pathogens & Disease, 2008
- Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigsVaccine, 2008
- Effect of Enteral Nutrition and Synbiotics on Bacterial Infection Rates After Pylorus-preserving PancreatoduodenectomyAnnals of Surgery, 2007
- Soluble Proteins Produced by Probiotic Bacteria Regulate Intestinal Epithelial Cell Survival and GrowthGastroenterology, 2007
- Perioperative Synbiotic Treatment to Prevent Postoperative Infectious Complications in Biliary Cancer SurgeryAnnals of Surgery, 2006
- The gut flora as a forgotten organEMBO Reports, 2006
- The complete genome sequence ofLactobacillus bulgaricusreveals extensive and ongoing reductive evolutionProceedings of the National Academy of Sciences of the United States of America, 2006
- Genetic Basis of Tetracycline and Minocycline Resistance in Potentially Probiotic Lactobacillus plantarum Strain CCUG 43738Antimicrobial Agents and Chemotherapy, 2006
- Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight NeonatesThe Journal of Pediatrics, 2005